Plus Therapeutics Inc (STU:XMP0) Stock News, Headlines & Updates
Plus Therapeutics Inc Stock News from GuruFocus
- 1
Jul 15, 2025
Plus Therapeutics Presents ReSPECT-LM Clinical Trial Results for REYOBIQâ„¢ in Patients with Leptomeningeal Metastases
Marketwired • 7:00am
Plus Therapeutics Presents ReSPECT-LM Clinical Trial Results for REYOBIQâ„¢ in Patients with Leptomeningeal Metastases | PSTV Stock News
GuruFocus News • 6:50am
Jul 10, 2025
Plus Therapeutics Announces Two CNSide Presentations at the Upcoming SNO/ASCO CNS Metastases Conference
Marketwired • 7:00am
Plus Therapeutics Announces Two CNSide Presentations at the Upcoming SNO/ASCO CNS Metastases Conference | PSTV Stock News
GuruFocus News • 6:47am
Jul 08, 2025
Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQâ„¢ in Leptomeningeal Metastases
Marketwired • 7:00am
Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQâ„¢ in Leptomeningeal Metastases | PSTV Stock News
GuruFocus News • 6:48am
Jun 30, 2025
Plus Therapeutics Announces FDA Agreement to Initiate ReSPECT-LM Dose Optimization Trial for REYOBIQâ„¢ in Leptomeningeal Metastases
Marketwired • 7:00am
Plus Therapeutics Announces FDA Agreement to Initiate ReSPECT-LM Dose Optimization Trial for REYOBIQâ„¢ in Leptomeningeal Metastases | PSTV Stock News
GuruFocus News • 6:48am
Jun 27, 2025
Plus Therapeutics (PSTV) Maintains Buy Rating Despite Price Target Cut | PSTV Stock News
GuruFocus News • 7:30am
H.C. Wainwright Adjusts Price Target for Plus Therapeutics (PSTV) | PSTV Stock News
GuruFocus News • 5:17am
Jun 26, 2025
Plus Therapeutics Provides Business Update on CNSide Diagnostics Subsidiary
Marketwired • 7:00am
Plus Therapeutics (PSTV) to Update on CNSide Diagnostics Business | PSTV Stock News
GuruFocus News • 6:50am
Plus Therapeutics Provides Business Update on CNSide Diagnostics Subsidiary | PSTV Stock News
GuruFocus News • 6:47am
Jun 25, 2025
Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, June 26, 2025 at 9:00 A.M. ET
Marketwired • 4:00pm
Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, June 26, 2025 at 9:00 A.M. ET | PSTV Stock News
GuruFocus News • 3:33pm
Plus Therapeutics (PSTV) Shares Surge After FDA Trial Clearance
GuruFocus News • 8:59am
PSTV Stock Update: D. Boral Capital Maintains Hold Rating for Plus Therapeutics | PSTV Stock News
GuruFocus News • 8:00am
Plus Therapeutics (PSTV) Gets FDA Nod for Pediatric Brain Cancer Trial | PSTV Stock News
GuruFocus News • 7:00am
Plus Therapeutics Announces FDA Clearance of its Investigational New Drug Application using REYOBIQTM for the Treatment of Childhood Brain Cancer
Marketwired • 7:00am
Plus Therapeutics Announces FDA Clearance of its Investigational New Drug Application using REYOBIQTM for the Treatment of Childhood Brain Cancer | PSTV Stock News
GuruFocus News • 6:46am
Jun 24, 2025
Plus Therapeutics Announces Comprehensive Restructuring of $15 Million March 2025 Equity Financing
Marketwired • 7:00am
Plus Therapeutics (PSTV) Restructures $15M Equity Financing to Minimize Dilution | PSTV Stock News
GuruFocus News • 6:52am
Plus Therapeutics Announces Comprehensive Restructuring of $15 Million March 2025 Equity Financing | PSTV Stock News
GuruFocus News • 6:47am
Jun 18, 2025
Plus Therapeutics (PSTV) Sees Stock Dip Amid New Share Sale Filing
GuruFocus News • 6:57am
Plus Therapeutics (PSTV) Announces Sale of 17 Million Shares | PSTV Stock News
GuruFocus News • 5:16am
Jun 05, 2025
PSTV: Ascendiant Capital Maintains Buy Rating and Raises Price Target | PSTV Stock News
GuruFocus News • 5:30am
Jun 02, 2025
Plus Therapeutics (PSTV) Reports Significant Q1 Earnings Miss
GuruFocus News • 11:55pm
May 30, 2025
Plus Therapeutics Reports First Quarter Financial Results and Recent Business Highlights
Marketwired • 4:00pm
Plus Therapeutics (PSTV) Reports Financial Gains from Grant Revenue and Financing | PSTV Stock News
GuruFocus News • 3:45pm
Plus Therapeutics Reports First Quarter Financial Results and Recent Business Highlights | PSTV Stock News
GuruFocus News • 3:31pm
May 23, 2025
Plus Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q
Marketwired • 4:00pm
Plus Therapeutics (PSTV) Faces Nasdaq Compliance Challenge
GuruFocus News • 3:56pm
Plus Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q | PSTV Stock News
GuruFocus News • 3:30pm
May 14, 2025
Plus Therapeutics (PSTV) Showcases Promising REYOBIQ Data at Conference | PSTV Stock News
GuruFocus News • 7:26am
Plus Therapeutics' REYOBIQ™ Shows Clinical Benefit and Safety in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases (LM)
Marketwired • 7:00am
Plus Therapeutics' REYOBIQ™ Shows Clinical Benefit and Safety in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases (LM) | PSTV Stock News
GuruFocus News • 6:52am
May 08, 2025
Plus Therapeutics to Participate in the D. Boral Capital Inaugural Global Conference
Marketwired • 6:00am
May 05, 2025
Plus Therapeutics (PSTV) Receives Downgrade to Hold by D. Boral Capital | PSTV Stock News
GuruFocus News • 7:00am
Plus Therapeutics (PSTV) Downgraded Amid Planned Reverse Stock Split | PSTV Stock News
GuruFocus News • 6:46am
Apr 23, 2025
Plus Therapeutics Announces Biotech Industry Veteran Kyle Guse Joins its Board of Directors
Marketwired • 7:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news